Awards and fellowships

Unleash your research potential with our grants and scholarships! In collaboration with partners from industry and research, we regularly offer research grants and scholarships for established and young researchers.

Apply now to drive your innovative projects forward!

To the winners

Registration deadline closed

Swiss Cancer Institute/AbbVie Digital Innovation Award

The use of artificial intelligence and digitalization has become increasingly important in medicine and hemato-oncology. The Swiss Cancer Institute/AbbVie Digital Innovation Award, sponsored by AbbVie, supports projects that pave the way for synergies between clinical research and information technology to improve standards of care. The prize is endowed with CHF 30'000.–.

Registration deadline closed

Swiss Cancer Institute/Astellas & AstraZeneca Translational GU Oncology Research Award

The Swiss Cancer Institute, together with Astellas and AstraZeneca, is pleased to announce the Translational GU Oncology Research Award. With a prize money of CHF 10,000, this award supports ongoing translational research projects in the field of urogenital oncology. The funding is provided in equal parts by Astellas and AstraZeneca and is intended to promote innovative approaches in clinical and translational research.

Registration deadline closed

Swiss Cancer Institute/Astellas GU-GI Research Award

In collaboration with Astellas, we have created the Swiss GU-GI Research Award to promote preclinical and clinical cancer research in Switzerland. The award is presented to a researcher on behalf of a research group or a research project and recognizes an outstanding scientific and/or clinical achievement that is part of a scientific publication (published article or already accepted manuscript for a peer-reviewed journal).

Registration deadline closed

Swiss Cancer Institute/AstraZeneca Transform Care Award

The Swiss Cancer Institute / AstraZeneca Transform Care Award recognizes and supports initiatives in oncology and hematology that can deliver systemic, above-medicine improvements to patient care across the Swiss healthcare system. The award is endowed with CHF 30’000.

Registration deadline closed

Swiss Cancer Institute/BMS HEM Pioneer Grant

Many types of blood cancer remain incurable and are associated with severe morbidity and increased mortality. The Swiss Cancer Institute/BMS HEM Pioneer Grant is funded by BMS and supports projects that can pave the way for a fundamental change in the treatment of blood cancer. The prize is endowed with CHF 20'000.–.

SwissCancerInstitute/BMS Grant «HEM Pioneer»

Registration deadline closed

Swiss Cancer Institute/Gilead Expanding Horizons in Oncology Award

The healthcare system is constantly evolving and the field of oncology is advancing particularly rapidly. In order to maintain high quality patient care, it is therefore particularly important to support the continuous education of healthcare providers in this field. Gilead, in partnership with the Swiss Cancer Institute, would like to contribute to meeting this challenge by funding continuing education in the field of oncology. The prize is endowed with CHF 40'000.–.

Registration deadline closed

Swiss Cancer Institute/Novartis Together for Patients Award

The Swiss Cancer Institute, in collaboration with Novartis, is offering a prize for innovative patient-centered projects in the field of breast cancer and chronic myeloid leukemia (CML). The prize is endowed with a maximum of CHF 30'000.– and supports ongoing or planned projects.

Registration deadline closed

Swiss Cancer Institute/Roche Young Investigator Award

The Swiss Cancer Institute/Roche Young Investigator Award aims to encourage and support talented young professionals in oncology with innovative ideas and clinical research projects that expand our understanding of the field and address emerging challenges in cancer care.

Sponsor an award now

Would you also like to sponsor and support interesting research projects?
Become a sponsoring partner and make a sustainable contribution to the future of clinical and translational oncology.